Tagged with research

UK Recipient of the 2018 Brain Prize for research for groundbreaking research on the generic and molecular basis of Alzheimer’s Disease, the UCL’s Professor John Hardy discusses recent progress in dementia research, the strengths and weaknesses of the UK’s medical research environment, and the potential effects of Brexit.   In all…

Ecuador Tania Mori Lucero, executive director of the Ecuadorian National Institute of Public Research (INSPI), details the entity’s role in supporting the elaboration of public health policies under the Ministry of Public Health’s umbrella. Mori highlights the important progress that has been made in the country’s research ecosystem and documents the…

Estonia Rauno Oja, managing director of AS EGeen, discusses the company’s geographical expansion during his tenure, turning to an international full-service CRO, EGeen’s commitment to high standards, and engagement with the community; carrying out communication activities on the ground in each country in which it operates. Rauno, you have worked for…

Canada Upon opening an R&D center in Mississauga in 2017, Biolab Pharma Canada, headed by Paulo Wickbold Marques, became the first Brazilian pharmaceutical company to establish an affiliate in Canada. In this interview, Paulo describes Biolab’s bold leap from Latin America, the strengths of the Canadian pharmaceutical landscape and how the…

UK Hilary Evans of Alzheimer’s Research UK (ARUK), the UK’s leading national research charity in the field of dementia, discusses her organization’s mission; the growing awareness of, and investment in, dementia research, care and diagnosis; and the enduring importance of international collaboration.   In the UK, when people want to help…

Canada Introducing Vantage BioTrials, a CRO focused on operational excellence with a lean and holistic approach to each project, Vatché Bartekian, president and co-founder, also advocates for greater visibility for Canada on the international stage and an increase in collaboration within the pharmaceutical industry and regulatory bodies. Vantage BioTrials celebrated its…

Switzerland Jonathan Koch, group president R&D Laboratories at Swiss-based CRO, Covance, explains how the integration process with LabCorb has progressed over the last two years, Covance’s embrace of digitally disruptive technologies, and becoming a “flexible service provider.” Two years on from LabCorp’s headline-making acquisition of Covance, how has the integration process…

Canada Dr. Roman Szumski, vice-president of life sciences at the National Research Council (NRC), Canada’s industrial innovation and research organization, highlights the strategic and operational changes that have occurred over the past decade, NRC’s focus on promoting biologics and vaccines development within Canada’s life sciences environment, and NRC’s work in promoting…

Tunisia Hechmi Louzir, general manager of the Institut Pasteur in Tunis (IPT), details the crucial role that the IPT plays in the development of the Tunisian health sector, his wide-ranging responsibilities as general manager, the increasing importance of building new partnerships between the private and public sectors, and the Institute’s ambition…

Austria Prof. Ruth Ladenstein, executive director of the Medicines for Children Research Organisation (OKIDS) in Austria, explains OKIDS’ drive to ensure drugs are paediatric specific by conducting child-specific clinical trials. Furthermore, she highlights the challenges associated with achieving a participating child’s consent and defines what must be done to gain governmental…

Austria Michael Stampfer, managing director of the Vienna Science and Technology Fund (WWTF), the only private, non-profit organization in Vienna dedicated to funding scientific research, discusses the challenges scientific research faces in Austria and how the organization helps bridge the gap between academia and industry. Furthermore, he illustrates the steps taken…

Austria Heidrun Katholnigg, executive director of global clinical development Europe for Celerion, a global CRO that specialises in phase I, II and III clinical trials, discusses the acquisition of Assign Group by Celerion in 2016 and the importance of Austria in managing European clinical operations. Furthermore, she highlights the favourable clinical…